Brief: Targovax Q1 Net Loss Widens To NOK 30.4 Million
May 12 (Reuters) - Targovax ASA TRVX.OL :
* Q1 OPERATING LOSS NOK 29.1 MILLION (NOT 29 072 MILLION)
VERSUS
LOSS NOK 23.0 MILLION YEAR AGO
* Q1 NET LOSS NOK 30.4 MILLION (NOT 30 437 MILLION) VERSUS
LOSS
NOK 22.5 MILLION YEAR AGO
* OUTLOOK: WITHIN THE NEXT 12 MONTHS WE EXPECT TO HAVE
SEVERAL
ACTIVE CLINICAL TRIALS INCLUDING BOTH OUR ONCOS AND TG PROGRAMS
Source text for Eikon: ID:nWkr78RHpX
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration